# Bristol-Myers Squibb Company (BMY) — Q2-2012 Earnings Results

**Report date:** 2012-07-25 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q2-2012

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Misses on EPS — Stock Up 0.63%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.48 | N/A | -1.64% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a cautious optimism about the future. They highlighted their focus on maintaining a strong pipeline despite current challenges.

**Key quotes:**

> Management emphasized ongoing commitment to innovation and pipeline development.

> They acknowledged challenges but expressed confidence in long-term growth.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report showed a slight miss on EPS, which may raise concerns among investors about profitability. However, the stock reacted positively, gaining 0.63%, likely due to management's focus on innovation and pipeline strength. The lack of revenue data and guidance leaves some uncertainty for future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q2-2012_